David A. Siegel Health Catalyst, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 29,700 shares of HCAT stock, worth $127,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,700
Previous 17,200
72.67%
Holding current value
$127,413
Previous $140,000
49.29%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding HCAT
# of Institutions
176Shares Held
50.5MCall Options Held
2.97MPut Options Held
16.1K-
Black Rock Inc. New York, NY5.43MShares$23.3 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN5.24MShares$22.5 Million3.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.39MShares$18.9 Million0.0% of portfolio
-
Impax Asset Management Group PLC2.75MShares$11.8 Million0.1% of portfolio
-
Daventry Group, LP New York, NY2.51MShares$10.8 Million6.78% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $235M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...